Robinson Pharma paid about $75 million for an Irvine industrial building, scuttling plans to redevelop the site into housing less than three months after investors acquired it for $52 million.

Robinson Pharma paid about $75 million for an Irvine industrial building, scuttling plans to redevelop the site into housing less than three months after investors acquired it for $52 million.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In
Professional, Scientific, and Technical Services
Manufacturing